Orbital pseudotumor

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 3, 2010, Pages 304-306

  Mendenhall, William M ^a   Lessner, Alan M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Orbital pseudotumor; Review

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG RESPONSE; EVISCERATION; EYE BIOPSY; EYE PAIN; EYE SURGERY; EYELID EDEMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT PSEUDOTUMOR; RECURRENCE RISK; REVIEW; TREATMENT OUTCOME; VISUAL ACUITY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORBITAL NEOPLASMS; ORBITAL PSEUDOTUMOR; TREATMENT OUTCOME;

EID: 77953351768     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181a07567     Document Type: Review

References (29)

1. Smitt MC, Donaldson SS. Radiation therapy for benign disease of the orbit. Semin Radiat Oncol. 1999;9:179-189.
2. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am. 2002;15:121-126.
3. Swamy BN, McCluskey P, Nemet A, et al. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007; 91:1667-1670.
4. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111:997-1008.
5. Mombaerts I, Goldschmeding R, Schlingemann RO, et al. What is orbital pseudotumor? Surv Ophthalmol. 1996;41:66-78.
6. Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit. Clinical, pathologic, and radiologic evaluation. Radiol Clin North Am 1999;37:151-68, xi.
7. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol. 2005;49:49-55.
8. Chirapapaisan N, Chuenkongkaew W, Pornpanich K, et al. Orbital pseudotumor: clinical features and outcomes. Asian Pac J Allergy Immunol. 2007; 25:215-218.
9. Yan J, Wu Z, Li Y. The differentiation of idiopathic inflammatory pseudotumor from lymphoid tumors of orbit: analysis of 319 cases. Orbit. 2004;23: 245-254.
10. McNicholas MM, Power WJ, Griffin JF. Idiopathic inflammatory pseudotumour of the orbit: CT features correlated with clinical outcome. Clin Radiol. 1991;44:3-7.
11. Yan J, Li Y, Qiu H, et al. Immunohistochemical study of the presence of mast cells in idiopathic orbital inflammatory pseudotumor: possible role of mast cells in the course of its pathogenesis. Int Ophthalmol. 2007;27:235-239.
12. Slavin ML, Glaser JS. Idiopathic orbital myositis: report of six cases. Arch Ophthalmol. 1982;100:1261-1265.
13. Weinstein GS, Dresner SC, Slamovits TL, et al. Acute and subacute orbital myositis. Am J Ophthalmol. 1983;96:209-217.
14. Mombaerts I, Schlingemann RO, Goldschmeding R, et al. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103:521-528.
15. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121:491-499.
16. Isobe K, Uno T, Kawakami H, et al. Radiation therapy for idiopathic orbital myositis: two case reports and literature review. Radiat Med. 2004;22:429-431.
17. Matsuo T, Sato Y, Kuroda R, et al. Systemic malignant lymphoma 17 years after bilateral orbital pseudotumor. Jpn J Ophthalmol. 2004;48:503-506.
18. Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol. 2002;13:347-351.
19. Garrity JA, Coleman AW, Matteson EL, et al. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138:925-930.
20. On AV, Hirschbein MJ, Williams HJ, et al. CyberKnife radiosurgery and rituximab in the successful management of sclerosing idiopathic orbital inflammatory disease. Ophthal Plast Reconstr Surg. 2006;22:395-397.
21. Char DH, Miller T. Orbital pseudotumor. Fine-needle aspiration biopsy and response to therapy. Ophthalmology. 1993;100:1702-1710.
22. Notter M, Kern T, Forrer A, et al. Radiotherapy of pseudotumor orbitae. Front Radiat Ther Oncol. 1997;30:180-191.
23. Weissler MC, Miller E, Fortune MA. Sclerosing orbital pseudotumor: a unique clinicopathologic entity. Ann Otol Rhinol Laryngol. 1989;98:496-501.
24. Fujii H, Fujisada H, Kondo T, et al. Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica. 1985;190:230-242.
25. Orcutt JC, Garner A, Henk JM, et al. Treatment of idiopathic inflammatory orbital pseudotumors by radiotherapy. Br J Ophthalmol. 1983;67:570-574.
26. Lanciano R, Fowble B, Sergott RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18:407-411.
27. Mittal BB, Deutsch M, Kennerdell J, et al. Paraocular lymphoid tumors. Radiology. 1986;159:793-796.
28. Austin-Seymour MM, Donaldson SS, Egbert PR, et al. Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys. 1985;11:371-379.
29. Sergott RC, Glaser JS, Charyulu K. Radiotherapy for idiopathic inflammatory orbital pseudotumor. Indications and results. Arch Ophthalmol. 1981;99:853-856.